ADCs in the Treatment of Breast Cancer and Gastric Cancer and Managing AEs Associated with ADCs

home / peer-exchange / adcs-in-the-treatment-of-breast-cancer-and-gastric-cancer-and-managing-aes-associated-with-adcs

A panel of experts in oncology review the use of antibody drug conjugates (ADCs) in breast and gastric cancers, defining optimal management of ADC-related adverse events.

Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive®